Loading…
Loading…
Dr. Reddy's Laboratories Limited (RDY) Q1 2027 Earnings Call Transcript
Dr. Reddy's Laboratories NYSE: RDY reported a year-over-year revenue decline and sharply lower profitability for the first quarter of fiscal 2027, as lower lenalidomide sales and semaglutide API-related challenges weighed on results. Management said the company's base business, excluding lenalidomide, continued to grow at a double-digit rate across key geographies.
Indian drugmaker Dr Reddy's reported a smaller-than-expected quarterly profit on Wednesday, as muted sales of a key generic oncology drug and pricing pressure weighed on the competitive U.S. market.
Bessemer Group Inc. boosted its holdings in shares of Dr. Reddy's Laboratories Ltd (NYSE: RDY) by 28.4% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,823,285 shares of the company's stock after buying an additional 403,219 shares during the period. Bessemer Group
Dr. Reddy's Laboratories NYSE: RDY said a scale-up issue tied to the active pharmaceutical ingredient for its semaglutide injection will temporarily delay commercial supplies, though management emphasized that products already supplied to the market are not affected and do not raise patient safety concerns.
Dr. Reddy's Laboratories Limited (RDY) Discusses Manufacturing Issue and Process Review for Semaglutide Transcript
Torrent Pharmaceuticals said on Thursday it was voluntarily recalling select batches of its Semalix semaglutide injection disposable pens after a product recall notification from its manufacturer Dr. Reddy's Laboratories.
HYDERABAD, India--(BUSINESS WIRE)---- $RDY #AmericanDepositaryReceipts--Dr. Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for RDY and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.